[Not Available].
To assess the implementation of the “Renewal of treatment for allergic rhino-conjunctivitis by community pharmacists” cooperation protocol in a multiprofessional medical home using four indicators—usefulness, efficiency, safety, and satisfaction—six months after implementation.
The intervention was carried out between April and November 2023. General practitioners and pharmacists/pharmacy assistants were invited to participate in the protocol. Inclusion criteria for patients were being between 15 and 50 years old, followed by a general practitioner affiliated with the medical home, and having a diagnosis of allergic rhinitis with a corresponding medication prescription. Usefulness was assessed as the proportion of patients managed by delegated professionals; efficiency, as the proportion of patients for whom the delegating general practitioner resumed follows-up; safety, as the occurrence of adverse events; and satisfaction, as assessed among professionals and patients.
Nine delegating general practitioners and 12 delegated pharmacists/pharmacy assistants participated in the protocol. Thirty-one patients were included and followed. Indicator results were 42.8% (usefulness), 87.1% (efficiency), 100% (safety), and 100% (satisfaction). Implementation of the protocol was limited in scope and by the complexity of administrative follow-up.
The protocol “Renewal of treatment for allergic rhino-conjunctivitis in pharmacies” is feasible and should be maintained, with consideration given to simplifications.
The intervention was carried out between April and November 2023. General practitioners and pharmacists/pharmacy assistants were invited to participate in the protocol. Inclusion criteria for patients were being between 15 and 50 years old, followed by a general practitioner affiliated with the medical home, and having a diagnosis of allergic rhinitis with a corresponding medication prescription. Usefulness was assessed as the proportion of patients managed by delegated professionals; efficiency, as the proportion of patients for whom the delegating general practitioner resumed follows-up; safety, as the occurrence of adverse events; and satisfaction, as assessed among professionals and patients.
Nine delegating general practitioners and 12 delegated pharmacists/pharmacy assistants participated in the protocol. Thirty-one patients were included and followed. Indicator results were 42.8% (usefulness), 87.1% (efficiency), 100% (safety), and 100% (satisfaction). Implementation of the protocol was limited in scope and by the complexity of administrative follow-up.
The protocol “Renewal of treatment for allergic rhino-conjunctivitis in pharmacies” is feasible and should be maintained, with consideration given to simplifications.